Administrative Core 1
Administrative Core 1
批准号:
10415935
负责人:
Michael Davies
金额:
$24.49万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-07-16 至 2024-05-31
关键词:
AdvocateAppointmentAwardBioinformaticsBiometryClinicalClinical TrialsCommunicationConsensusConsultationsData CommonsDevelopmentDisciplineDiseaseEnsureFundingGoalsGovernmentLeadershipMaintenanceMentorsMinorityMonitorPatient CarePatientsPoliciesPreparationProcessPublicationsQuality ControlRegulationReportingResearchResearch PersonnelResourcesRoleScheduleScientistSiteSkin CancerTimeUnited States National Institutes of HealthUniversity of Texas M D Anderson Cancer CenterWomancareerdata qualitydata repositorydata sharingdata standardsexperienceflexibilityinterdisciplinary approachlecturesmeetingsmelanomaprogramsquality assurancerecruitsymposium
中文摘要
管理核心1:项目总结/摘要
在SPORE框架内,行政核心(核心1)将负责纳入
将SPORE研究人员的不同科学学科整合为高度集成的跨学科方法
专注于实现卓越的转化黑色素瘤研究,对护理产生重大影响
与这种疾病作斗争的病人。该小组的主要目标是确保成功的持续监督
并通过专家协调所有项目、核心项目以及发展和职业提升计划
指导财务管理、集中沟通和所有活动的一般管理。这
核心将由三位杰出的科学家和公认的导师领导,他们目前拥有高级别的
在MD安德森的行政,研究和/或临床任命,并拥有数十年的组合
领导经验:帕特里克胡博士,伊丽莎白格林和杰弗里E。李你
行政核心的具体职责包括:
·遵守所有机构、联邦和NIH/NCI法规和要求。
·与NCI项目官员和其他NCI工作人员进行沟通和协商,包括准备
所有要求的报告、出版物和其他要求的通信。
·与生物统计学和
生物信息学核心(核心3)。
·优化临床试验工作,包括监测和加强相关的累积进展
通过临床试验管理资源(由Hwu博士和
李先生)住在这个行政核心内。
·维持财政和预算责任,包括实施SPORE灵活性
通过持续评估计划进展情况和供资理由,酌情选择
分配/再分配。
·召开所有必要的会议,包括执行委员会、内部和外部咨询委员会
委员会(IAB/EAB),科学会议,研究会议,讲座和研讨会,包括
安排、编制和分发会议材料,并酌情记录会议记录。
·协调和资助患者维权活动。
·制定和监测在这方面征聘和保留妇女和少数民族的政策
程序.
·与其他SPORE站点协调,以启动和加强合作研究工作,
赞助一年一度的皮肤癌会议,并寻求高潜力的发展机会
研究计划(DRP)和职业提升计划(CEP)的申请,
合作调查员。
英文摘要
Adminstrative Core 1: Project Summary/Abstract
Within the SPORE framework, the Administrative Core (Core 1) will be responsible for incorporating the
diverse scientific disciplines of the SPORE investigators into a highly integrated, interdisciplinary approach
focused on achieving excellence in translational melanoma research towards a significant impact on the care
of patients battling this disease. The primary goal of this group is to assure the successful continued oversight
and coordination of all projects, cores, and developmental and career enhancement programs through expert
guidance in fiscal management, centralized communication, and general administration for all activities. This
core will be led by three outstanding scientists and well-established mentors who currently hold high-level
administrative, research, and/or clinical appointments at MD Anderson and possess decades of combined
leadership experience: Drs. Patrick Hwu, Elizabeth Grimm, and Jeffrey E. Lee.
Specific responsibilities of the Administrative Core include the following:
· Compliance with all institutional, federal, and NIH/NCI regulations and requirements.
· Communication and consultation with the NCI project officer and other NCI staff, including preparation
of all required reports, publications, and other requested communications.
· Monitoring data quality control and assurance activities in conjunction with the Biostatistics and
Bioinformatics Core (Core 3).
· Optimization of clinical trial efforts, including monitoring and enhancing accrual progress of related
SPORE clinical trials, through the Clinical Trials Management Resource (co-directed by Dr. Hwu and
Lee) housed within this Administrative Core.
· Maintenance of fiscal and budgetary responsibilities, including implementing the SPORE flexibility
option as appropriate through ongoing assessments of program progress and justifications for funding
allocations/reallocations.
· Convening all necessary meetings, including the Executive Committee, Internal and External Advisory
Boards (IAB/EAB), scientific meetings, research meetings, lectures, and symposia, including
scheduling, development and distribution of meeting materials, and recording minutes as appropriate.
· Coordination and funding of Patient Advocate activities.
· Establishment and monitoring of policies for recruitment and retention of women and minorities in this
program.
· Coordination with other SPORE sites to initiate and enhance collaborative research efforts, co-
sponsor a yearly Skin Cancer conference, and pursue opportunities for high potential Developmental
Research Program (DRP) and Career Enhancement Program (CEP) applications from
collaborating investigators.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The University of Texas MD Anderson Cancer Center SPORE in Melanoma
-
批准号:10415934
-
项目类别:
-
资助金额:$205.87万
-
财政年份:2019
-
负责人:Michael Davies
-
依托单位:
Administrative Core 1
-
批准号:10683943
-
项目类别:
-
资助金额:$24.34万
-
财政年份:2019
-
负责人:Michael Davies
-
依托单位:
The University of Texas MD Anderson Cancer Center SPORE in Melanoma
-
批准号:9978748
-
项目类别:
-
资助金额:$212.8万
-
财政年份:2019
-
负责人:Michael Davies
-
依托单位:
Project 1 Targeting the PI3K Pathway to Overcome Resistance to Immunotherapy in Melanomas with Loss of PTEN
-
批准号:10208808
-
项目类别:
-
资助金额:$38.73万
-
财政年份:2019
-
负责人:Michael Davies
-
依托单位:
The University of Texas MD Anderson Cancer Center SPORE in Melanoma
-
批准号:10208804
-
项目类别:
-
资助金额:$194.39万
-
财政年份:2019
-
负责人:Michael Davies
-
依托单位:
The University of Texas MD Anderson Cancer Center SPORE in Melanoma
-
批准号:10683940
-
项目类别:
-
资助金额:$207.04万
-
财政年份:2019
-
负责人:Michael Davies
-
依托单位:
Project 1 Targeting the PI3K Pathway to Overcome Resistance to Immunotherapy in Melanomas with Loss of PTEN
-
批准号:10683948
-
项目类别:
-
资助金额:$41.25万
-
财政年份:2019
-
负责人:Michael Davies
-
依托单位:
Project 1 Targeting the PI3K Pathway to Overcome Resistance to Immunotherapy in Melanomas with Loss of PTEN
-
批准号:10415938
-
项目类别:
-
资助金额:$41.5万
-
财政年份:2019
-
负责人:Michael Davies
-
依托单位:
Rational approaches to melanoma therapy
-
批准号:10013137
-
项目类别:
-
资助金额:$140.04万
-
财政年份:2017
-
负责人:Michael Davies
-
依托单位:
Rational approaches to melanoma therapy
-
批准号:10681839
-
项目类别:
-
资助金额:$58.97万
-
财政年份:2017
-
负责人:Michael Davies
-
依托单位:
Research Project 2 - Targeting Melanoma Tumor Survival and Apoptotic Machinery
-
批准号:10681845
-
项目类别:
-
资助金额:$12.97万
-
财政年份:2017
-
负责人:Michael Davies
-
依托单位:
Research Project 2 - Targeting Melanoma Tumor Survival and Apoptotic Machinery
-
批准号:10013152
-
项目类别:
-
资助金额:$30.8万
-
财政年份:2017
-
负责人:Michael Davies
-
依托单位:
Rational approaches to melanoma therapy
-
批准号:9985257
-
项目类别:
-
资助金额:$143.09万
-
财政年份:2017
-
负责人:Michael Davies
-
依托单位:
Rational approaches to melanoma therapy
-
批准号:10251033
-
项目类别:
-
资助金额:$139.18万
-
财政年份:2017
-
负责人:Michael Davies
-
依托单位:
Research Project 2 - Targeting Melanoma Tumor Survival and Apoptotic Machinery
-
批准号:10251044
-
项目类别:
-
资助金额:$30.8万
-
财政年份:2017
-
负责人:Michael Davies
-
依托单位:
Rational Approaches to Melanoma Therapy
-
批准号:10733192
-
项目类别:
-
资助金额:$63.55万
-
财政年份:2017
-
负责人:Michael Davies
-
依托单位:
Research Project 2 - Targeting Melanoma Tumor Survival and Apoptotic Machinery
-
批准号:9446227
-
项目类别:
-
资助金额:$64.52万
-
财政年份:2017
-
负责人:Michael Davies
-
依托单位:
Rational approaches to melanoma therapy (PDXNet Administrative Supplement to R01CA241148)
-
批准号:10371682
-
项目类别:
-
资助金额:$12.0万
-
财政年份:2017
-
负责人:Michael Davies
-
依托单位:
Rational approaches to melanoma therapy (PDXNet Administrative Supplement to R01CA121118)
-
批准号:10371684
-
项目类别:
-
资助金额:$12.0万
-
财政年份:2017
-
负责人:Michael Davies
-
依托单位:
Personalized targeting of anti-apoptosis pathways to overcome therapeutic resistance in melanoma
-
批准号:10733197
-
项目类别:
-
资助金额:$13.03万
-
财政年份:2017
-
负责人:Michael Davies
-
依托单位:
海外基金